AmeriCann, Inc. (ACAN)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

Mar 6, 2026, 9:30 AM EST

-99.67% (1Y)

Market Cap	2.44K
Revenue (ttm)	799.18K
Net Income (ttm)	-2.38M
Shares Out	24.39M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,863
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	-0.21
RSI	46.46
Earnings Date	Dec 24, 2025

About AmeriCann

AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company’s flagship project is the Massachusetts Cannabis Center that is developed on a 52.6 -acre parcel of undeveloped land located in Freetown, Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is headquartered in Denver, Colorado. [Read more]

Industry Real Estate Services

Sector Real Estate

Founded 2010

Employees 3

Stock Exchange OTCMKTS

Ticker Symbol ACAN

Full Company Profile

Financial Performance

In fiscal year 2024, AmeriCann's revenue was $1.27 million, a decrease of -50.05% compared to the previous year's $2.55 million. Losses were -$1.25 million, 1223.8% more than in 2023.

Financial Statements

News

There is no news available yet.